Mel B. Glenn, MD

Associate Professor  
mglenn@partners.org 617-573-2625 617-573-2769  
Director of Outpatient & Community Brain Injury Rehabilitation  
Physical Medicine and Rehabilitation 
Spaulding Rehabilitation Hospital

Clinical interests: Brain injury; Spasticity  Research interests: Brain injury rehabilitation; Cognitive rehabilitation; Psychopharmacology in brain injury 

Education:
MD, New York University School of Medicine, 1978 
New York University Medical Center,Physical Medicine & Rehabilitation, 1981 
New York University Medical Center, Spinal Cord Injury Rehabilitation, 1982
Physical Medicine & Rehabilitation, 1982 

In Brief:
Prior to his arrival at Spaulding Rehabilitation Hospital in 1998, Dr Glenn served on the staff and faculty at New England Medical Center/Tufts University School of Medicine and at Boston University Medical Center, where he was Chief and Chairman of the Department of Rehabilitation Medicine. Dr. Glenn has given more than 100 regional, national and international presentations on topics on rehabilitation following brain injury and spasticity management. He is a reviewer for several journals, including the Journal of Head Trauma Rehabilitation, for which he edits the "Update on Pharmacology" column and serves on the editorial board. 

Publications:
Original Articles:   
Glenn MB. Update on pharmacology: Sudden cardiac death and stroke with the use of antipsychotic medications: Implications for clinicians treating individuals with traumatic brain injury. J Head Trauma Rehabil 2010;25(1):68-70.     
O'Neil-Pirozzi TM, Strangman GE, Goldstein R, Katz DI, Savage CR, Kelkar K, Supelana C, Burke D, Rauch SL, Glenn MB.
A controlled treatment study of internal memory sStrategies (I-MEMS) following traumatic brain injury. J Head Trauma Rehabil 2010;25(1):43-51.   
Al-Adawi S, Dorvlo AS, Al-Naamani A, Glenn MB, Karamouz N, Chae H, Zaidan ZA, Burke DT.  The ineffectiveness of the Hospital Anxiety and Depression Scale for diagnosis in an Omani traumatic brain injured population. Brain Inj 2007
Apr;21(4):385-93.    Strangman GE, O'Neil-Pirozzi TM, Goldstein R, Kelkar K, Katz DI, Burke D, Rauch SL, Savage CR, Glenn MB.
Prediction of memory rehabilitation outcomes in traumatic brain injury using functional magnetic resonance imaging. Arch Phys Med Rehabil 2008;89:974-81.   
Strangman GE, Goldstein R, O'Neil-Pirozzi TM, , Kelkar K, Supelana C, Burke D, Katz DI, Rauch SL, Savage CR, Glenn MB.
Neurophysiological alterations during strategy-based verbal learning in traumatic brain injury. Neurorehabilitation Neural Repair 2009;23(3):226-36.   
Kreutzer JS, Rapport LJ, Marwitz JH, Harrison-Felix C, Hart T, Glenn M, Hammond F. Caregivers? well-being after traumatic brain injury: a multicenter prospective investigation. Arch Phys Med Rehabil 2009;90:939-946.  
 Glenn MB, et al. Serum albumin as a predictor of course and outcome on a rehabilitation service. Arch Phys Med Rehabil 1985;66:294-297.   
Wroblewski BA, Glenn MB, Whyte J, Singer WD. Carbamazepine replacement of phenytoin, phenobarbital and primidone in a rehabilitation setting: Effects on seizure control. Brain Injury  1989;3:149-156.   
Whyte J, Martin TR, Glenn MB, Gutowski W, Wroblewski B, Reger J. Quantification of attention-related behaviors in individuals with traumatic brain injury. Am J Phys Med Rehabil 1994;73:2-9.   
Glenn MB, O'Neil-Pirozzi T, Goldstein R, Burke D, Jacob L.  Depression amongst outpatients with traumatic brain injury. Brain Inj 2001;15(9):811-818.   
Glenn MB, Burke DT, O'Neil-Pirozzi T, Goldstein R, Jacob L, Kettell J. Cutoff score on the Apathy Evaluation Scale in subjects with traumatic brain injury. Brain Inj 2002; 16:509-516.    Burke DT, Glenn, MB, Vesali F, Schneider JC, Burke J, Ahanger B, Goldstein R. The effects of methylphenidate on heart rate and blood pressure among inpatients with acquired brain injury. Am J Phys Med Rehabil 2003; 82:493-497.    O'Neil-Pirozzi TM, Kendrick H, Goldstein R, Glenn M.  Clinician influences on use of portable electronic memory devices in traumatic brain injury rehabilitation.  Brain Inj 2004;18(2):179-189.    
Glenn MB, Goldstein R, Selleck E, Rotman M. Characteristics of facility-based community integration programs for people with brain injury. J Head Trauma Rehabil 2004;19(6):482-493.  
 Glenn MB, Rotman M, Goldstein R, Selleck E. Characteristics of residential community integration programs for adults with brain injury. J Head Trauma Rehabil 2005;20(5):393-401.   
Glenn MB, Selleck E, Goldstein R, Rotman M. Characteristics of home-based community integration programs for adults with brain injury. Brain Inj 2005;19:1243-1247.   
Glenn MB, Goldstein R, Selleck E, Rotman M, Jacob L. Validity and reliability of the Community Integration Program Questionnaire. Int J Rehabil Research 2006 Jun;29(2):117-21.    

Reviews, Chapters, and Editorials:   
Glenn MB. Post-concussion disorders. In Frontera W, Silver J, editors. Essentials of Rehabilitation Medicine, 2nd Ed. Philadelphia: Hanley & Belfus, 2008, p. 801-806.    Glenn MB. Botulinum Neurotoxin for Spasticity (Summary and Comment). Journal Watch Neurology, July 8, 2008.   
Glenn MB, Rosenthal M. Rehabilitation following severe traumatic brain injury. Seminars in Neurology 1985;5:233-246.   
Glenn MB, Wroblewski B. Update on pharmacology: Anticonvulsant prophylaxis of post-traumatic seizures. J Head Trauma Rehabil 1986;1(1):73-74.   
Whyte J, Glenn MB. The care and rehabilitation of the patient in a persistent vegetative state. J Head Trauma Rehabil 1986;1(1):39-53.   
Glenn MB, Wroblewski B. Update on pharmacology: Antispasticity medications in the patient with traumatic brain injury. J Head Trauma Rehabil 1986;1(2):71-72.   
Glenn MB. Update on pharmacology: Nerve blocks in the treatment of spasticity. J Head Trauma Rehabil 1986;1(3):72-74.   
Glenn MB. Update on pharmacology: Central nervous system stimulants: Applications in traumatic brain injury. J Head Trauma Rehabil 1986;1(4):74-76.  
 Glenn MB, Josephs AB. The use of lithium for behavioral and affective disorders after traumatic brain injury. J Head Trauma Rehabil 1987;2(4):68-76.   
Glenn MB. Update on pharmacology: A pharmacological approach to aggressive and disruptive behaviors after traumatic brain injury (Part 1). J Head Trauma Rehabil 1987;2(1):71-73.   
Glenn MB. Update on pharmacology: A pharmacological approach to aggressive and disruptive behaviors after traumatic brain injury (Part 2). J Head Trauma Rehabil 1987;2(2):80-81.   
Glenn MB. Update on pharmacology: A pharmacological approach to aggressive and disruptive behaviors after traumatic brain injury (Part 3). J Head Trauma Rehabil 1987;2(3):85-87.       
Wroblewski B, Glenn MB. Update on pharmacology: Chronic hypertension after traumatic brain injury: Pharmacologic options. J Head Trauma Rehabil 1987;2(4):87-89.    Whyte J, Glenn MB. Management of the patient in a persistent vegetative state. In: Bach-y-Rita, P, editor. Traumatic brain injury: current status and a research agenda. New York:  Demos Publications; 1989. p. 13.  
 Glenn MB, Wroblewski B, Parziale J, Levine L, Whyte J, Rosenthal M: Lithium carbonate for aggressive behavior or affective instability in ten brain-injured patients.  Am J Phys Med Rehabil 1989;68:221-226.   
Frisch SG, Glenn MB. Clinical use of nerve blocks for functional improvement. Surg Rounds for Orthopaedics 1989;3(4):79-87.   
Glenn MB, Wroblewski B. Update on pharmacology: The choice of antidepressants after traumatic brain injury. J Head Trauma Rehabil 1989;4(3):85-88.   
Gans BM, Glenn MB. Introduction. In: Glenn MB, Whyte J, editors. The practical management of spasticity in children and adults. Philadelphia: Lea and Febiger; 1990. p.1.   
Glenn MB. Nerve blocks. In: Glenn MB, Whyte J, editors. The practical management of spasticity in children and adults. Philadelphia: Lea and Febiger; 1990. p. 227.    Glenn MB. The management of spasticity after traumatic brain injury. In: Glenn MB, Whyte J, editors. The practical management of spasticity in children and adults. Philadelphia: Lea and Febiger; 1990. p. 296.   
Glenn MB. Update on pharmacology: Anticonvulsants reconsidered. J Head Trauma Rehabil 1991;6(3):85-88.   
Wroblewski B, Glenn MB, Cornblatt R, Joseph AB, Suduikis S. Protriptyline as an alternative stimulant medication in patients with brain injury: A series of case reports.  Brain Injury  1993;7:353-362.   
Glenn MB. Update on pharmacology: Etidronate disodium: effects on heterotopic ossification and osteoporosis. J Head Trauma Rehabil 1993;8(3):99-103.   
Glenn MB. Nerve Blocks for the treatment of spasticity. In: Katz R, editor: Spasticity. Physical Medicine and Rehabilitation State of the Art Reviews Vol 3., No.8. Philadelphia: Hanley and Belfus; 1994. p. 481.   
Wroblewski B, Glenn MB. Treatment of arousal and cognitive deficits. J Head Trauma Rehabil 1994(3):19-41.   
Glenn MB. Update on pharmacology: Zolpidem. J Head Trauma Rehabil 1995; 11(2):96-98.   
Wroblewski B, Glenn MB. Pharmacologic treatment for survivors of severe brain injury.  In: Levin HS, Benton AL, Muizelaar JP, Eisenberg GM , editors. Catastrophic brain injury. New York: Oxford University Press; 1996. p. 93.   
Glenn MB. Guest Editorial: Physical therapy for very frail elderly. Rehab in Review 1996;4(1):1.   
Glenn MB, Biener Bergman S. Cardiovascular changes following spinal cord injury. Top Spinal Cord Inj Rehabil 1997;2(4):47-53.   
Glenn MB, Elovic E. Chemical denervation in the treatment of hypertonia and other motor disorders: Phenol and botulinum toxin. J Head Trauma Rehabil 1997;12(6):40-62.    Glenn MB. Update on pharmacology: The role of methylphenidate in cognitive and behavioral dysfunction following traumatic brain injury. J Head Trauma Rehabil 1998; 13(5):87-90.   
Glenn MB. Post-concussion syndrome. In Frontera W, Silver J, editors. Essentials of Rehabilitation Medicine. Philadelphia: Hanley & Belfus, 2001, pp. 687-693.   
Glenn, MB. A differential diagnostic approach to the pharmacologic treatment of cognitive, behavioral, and affective disorders after traumatic brain injury. J Head Trauma Rehabil 2002;17(4):273-283.   
Glenn MB, Biener Bergman S. Rehabilitation of neurologic disability. In: Samuels MA, Feske S, editors. Office practice of neurology. Philadelphia: Churchill Livingstone; 1996; 2nd Edition, 2003, pp 243-250.   
Strangman G, ONeil-Pirozzi TM, Burke D, Cristina D, Goldstein R, Rauch SL, Savage CR, Glenn MB. Functional neuroimaging and cognitive rehabilitation for people with traumatic brain injury. Am J Phys Med Rehabil 2005;84:62-75.   
Glenn MB, Wroblewski B. Twenty years of pharmacology. J Head Trauma Rehabil 2005;20:51-61.    Glenn, M. The Apathy Evaluation Scale. The Center for Outcome Measurement in Brain Injury 2005, http://www.tbims.org/combi/aes (June 29, 2005 ).    Books:    Glenn MB, Whyte J, editors. The practical management of spasticity in children and adults. Philadelphia: Lea and Febiger; 1990.   
Clinical Communications:    Glenn MB. Control of muscles after brain injury. In: Family Articles for Traumatic Brain Injury. Communication Skill Builders. Tucson, 1994.    American Congress of Rehabilitation Medicine (Giacino JT, Zasler ND, Whyte J, Katz D, Glenn MB). Recommendations for use of uniform nomenclature pertinent to patients with severe alterations in consciousness: Position paper. Arch Phys Med Rehabil 1995;76:205-209.   
Kerrigan DC, Glenn MB. Clinical gait laboratory use to improve rehabilitation management.  Am J Phys Med Rehabil 1995;73:421-427.   
Lee LW, Glenn MB. Adrenal insufficiency masquerading as sepsis in a patient with tetraparesis: a case report. Arch Phys Med Rehabil 2000;81:830-833.